Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure

Heart

Volumn 79, Issue 3, 1998, Pages 281-288

  Pagano, D ^a   Bonser, R S ^a   Townend, J N ^b   Ordoubadi, F ^c   Lorenzoni, R ^c   Camici, P G ^c  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b Queen Elizabeth Hospital

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Coronary artery disease; Dobutamine echocardiography; Heart failure; Hibernating myocardium; Positron emission tomography

Indexed keywords

DOBUTAMINE; FLUORODEOXYGLUCOSE F 18; PERTECHNETIC ACID TC 99M;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE ISCHEMIA; HUMAN; MALE; MYOCARDIAL DISEASE; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031954374     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.79.3.281     Document Type: Article

References (42)

1. Diamond G, Forrester J, deLuz P, et al. Post-extrasystolic potentiation of ischaemic cardiomyopathy by atrial stimulation. Am Heart J 1978;95:204-9.
2. Rahimtoola S. Coronary bypass surgery for chronic angina - 1981: a perspective. Circulation 1982;65:225-41.
3. Dreyfus G, Duboc D, Blasco A, et al. Myocardial viability assessment in ischaemic cardiomyopathy: benefits of coronary revascularisation. Ann Thorac Surg 1994;57: 1402-8.
4. vom Dahl J, Eitzman DT, al Aouar ZR, et al. Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation 1994;90:2356-66.
5. Gioia G, Powers J, Heo J, et al. Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischaemic cardiomyopathy. Am J Cardiol 1995;75:759-62.
6. Lee S, Marwick T, Cook S, et al. Prognisis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularisation. Circulation 1994; 90:2687-94.
7. Pagley P, Beller G, Watson D, et al. Improved outcome after coronary artery bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 1997;96:793-800.
8. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 1993;87:1-20.
9. Bonow R. Identification of viable myocardium. Circulation 1996;94:2674-8.
10. Baer M, Voth E, Deutsch J, et al. Assessment of viable myocardium by dobutamine transesophageal echocardiography and comparison with fluorine-18-fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 1994;24:343-53.
11. Hepner A, Bach S, Bolling S, et al. A positive dobutamine stress echocardiogram predicts viable myocardium in ischaemic cardiomyopathy: a comparison with PET [abstract]. Circulation 1994;90(suppl):1-117.
12. Perrone-Filardi P, Pace L, Prastraro M, et al. Assessment of myocardial viability in patients with chronic coronary artery disease. Rest-4-hour-24-hour 201-thallium tomography versus dobutamine echocardiography. Circulation 1996;94:2712-19.
13. Pirelli S, Crivellaro W, Faletra F, et al. Dobutamine stress echocardiography and rest thallium-201 scintigraphy in patients with previous myocardial infarction and single coronary artery lesion: prediction of functional recovery after revascularisation [abstract]. J Am Coll Cardiol 1995;25(suppl):340A.
14. Gerber B, Vanovershelde J-L, Bol A, et al. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. Circulation 1996;94:651-9.
15. Pagano D, Camici P, Townend J, et al. Coronary artery bypass grafting for congestive heart failure [abstract]. Circulation 1996;94(suppl):I-232.
16. Zaret BL, Wackers FJ. Nuclear cardiology (second of two parts). N Engl J Med 1993;329:855-63.
17. Bland M, Airman D. Statistical methods for assessing agreement between two methods of clinical measurements. Lancet 1986;i:307-10.
18. Segar D, Brown S, Sawada S, et al. Dobutamine stress echocardiography: correlation with coronary lesion severity as determined by quantitative angiography. J Am Coll Cardiol 1992;19:1197-202.
19. Marinho N, Keogh B, Costa D, et al. Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilisation. Circulation 1996;93:737-44.
20. Fath-Ordoubadi F, Marinho N, Keogh B, et al. Value of positron emission tomography in predicting functional recovery following coronary revascularisation: effect of baseline wall motion score and ejection fraction [abstract]. Eur Heart J 1995;16(suppl):129.
21. Metz C. Basic principles of ROC analysis. Semin Nucl Med 1978;8:283-98.
22. Bax J, Cornel J, Visser F, et al. Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/thallium SPECT. Thallium-201 stress-reinjection and dobutamine echocardiography. J Am Coll Cardiol 1996;28:558-64.
23. Ausma J, Cleutjens J, Thone' F, et al. Chronic hibernating myocardium: interstitial changes. Mol Cell Biochem 1995; 147:35-42.
24. Ausma J, Furst D, Shivalkar B, et al. Molecular changes of titin in left ventricular dysfunction as a result of chronic hibernation. J Mol Cell Cardiol 1995;27:1202-12.
25. Camici PG, Wijus W, Borgers M, et al. Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium). Circulation 1997;96:3205-14.
26. Armstrong W. "Hibernating" myocardium: asleep or part dead? J Am Coll Cardiol 1996; 8:530-5.
27. Kaul S. There may be more viability that meets the eyel Circulation 1995;92:2790-93.
28. Di Carli M, Davidson M, Little R, et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73:527-33.
29. Eitzman D, Za A, Kanter HL, et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography [see comments]. J Am Coll Cardiol 1992;20:559-65.
30. Camici P, Ferranini E, Opie L. Myocardial metabolism in ischaemic heart disease: basic principles and applications to imaging by positron emission tomography. Progr Cardiovasc Dis 1989;32:217-38.
31. 18FDG uptake in chronic coronary artery disease. Nuclear Medicine Communications 1995;16:548-57.
32. Panza J, Dilsizian V, Laurienzo J, et al. Relation between thallium uptake and contractile response to dobutamine. Implications regarding myocardial viability in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation 1995;91:990-8.
33. Bristow M, Ginsburg R, Minoke W, et al. Decreased catecholamine sensitivity and B-adrenergic-receptor density in failing human hearts. N Engl J Med 1982;307:205-21.
34. Pagano D, Bonser R, Townend J, et al. Histopathological correlates of dobutamine echocardiography in hibernating myocardium [abstract]. Circulation 1996;94(suppl):I-231.
35. Depre' C, Vanoverschelde J, Melin J, et al. Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. Am J Physiol 1995;268:H1265-75.
36. Vanoverschelde JJ, Wijns W, Depre' C, et al. Mechanism of chronic regional postischaemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation 1993;87:1513-23.
37. Chen C, Chen L, Prada J, et al. Incremental doses of dobutamine induce a biphasic response in dysfunctional left ventricular regions subtending coronary stenoses. Circulation 1995;92:756-66.
38. Cohn J, Johnson J, Shabetai R, et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhytmias, and plasma noreepinephrine as determinants of prognosis in heart failure. Circulation 1993; 87(suppl):VI-5-16.
39. Hochberg M, Parsonnet V, Gielchinsky I, et al. Coronary artery bypass grafting in patients with ejection fractions below forty percent. J Thorac Cardioasc Surg 1983;86: 519-27.
40. Afridi I, Kleiman N, Raizner A, et al. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995;91:663-70.
41. La Canna G, Alfieri O, Giubbini R, et al. Echocardiography during infusion of dobutamine for identification of reversibly dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 1994;23:617-26.
42. Castini D, Gentile M, Ornaghi M, et al. Dobutamine echocardiography: usefulness of digital image processing. Eur Heart J 1995;16:1420-4.